Vincent Bours
Vincent Bours
Université de Liège
Verified email at uliege.be
Title
Cited by
Cited by
Year
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
P Viatour, MP Merville, V Bours, A Chariot
Trends in biochemical sciences 30 (1), 43-52, 2005
15172005
The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers
V Bours, G Franzoso, V Azarenko, S Park, T Kanno, K Brown, U Siebenlist
Cell 72 (5), 729-739, 1993
6411993
NF-κ B transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj, V Barbu, M Fillet, A Chariot, B Relic, N Jacobs, J Gielen, ...
Oncogene 22 (1), 90-97, 2003
5512003
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B
RP Ryseck, P Bull, M Takamiya, V Bours, U Siebenlist, P Dobrzanski, ...
Molecular and cellular biology 12 (2), 674-684, 1992
4651992
The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition
G Franzoso, V Bours, S Park, M Tomfta-Yamaguchi, K Kelly, U Siebenlist
Nature 359 (6393), 339-342, 1992
4121992
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site
V Bours, PR Burd, K Brown, J Villalobos, S Park, RP Ryseck, R Bravo, ...
Molecular and Cellular Biology 12 (2), 685-695, 1992
3521992
Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs
V Bours, J Villalobos, PR Burd, K Kelly, U Siebenlist
Nature 348 (6296), 76-80, 1990
3511990
Nuclear factor-κB, cancer, and apoptosis
V Bours, M Bentires-Alj, AC Hellin, P Viatour, P Robe, S Delhalle, ...
Biochemical pharmacology 60 (8), 1085-1089, 2000
3212000
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families
AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ...
The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007
3202007
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
AF Daly, MA Tichomirowa, P Petrossians, E Heliövaara, ML Jaffrain-Rea, ...
The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010
3112010
Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity
G Bonizzi, J Piette, S Schoonbroodt, R Greimers, L Havard, MP Merville, ...
Molecular and cellular biology 19 (3), 1950-1960, 1999
2771999
The NF-κB transcription factor and cancer: high expression of NF-κB-and IκB-related proteins in tumor cell lines
V Bours, E Dejardin, F Goujon-Letawe, MP Merville, V Castronovo
Biochemical pharmacology 47 (1), 145-149, 1994
2561994
Multiple redox regulation in NF-kappaB transcription factor activation.
J Piette, B Piret, G Bonizzi, S Schoonbroodt, MP Merville, ...
Biological chemistry 378 (11), 1237-1245, 1997
2531997
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G Trivellin, AF Daly, FR Faucz, B Yuan, L Rostomyan, DO Larco, ...
New England Journal of Medicine 371 (25), 2363-2374, 2014
2522014
The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
G Franzoso, V Bours, V Azarenko, S Park, M Tomita‐Yamaguchi, T Kanno, ...
The EMBO journal 12 (10), 3893-3901, 1993
2251993
NF-κ B2/p100 induces Bcl-2 expression
P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L de Leval, ...
Leukemia 17 (7), 1349-1356, 2003
2202003
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia
P Close, N Hawkes, I Cornez, C Creppe, CA Lambert, B Rogister, ...
Molecular cell 22 (4), 521-531, 2006
2122006
An insertion–deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases
V Dideberg, G Kristjansdottir, L Milani, C Libioulle, S Sigurdsson, E Louis, ...
Human molecular genetics 16 (24), 3008-3016, 2007
1992007
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and …
CA Stratakis, MA Tichomirowa, S Boikos, MF Azevedo, M Lodish, ...
Clinical genetics 78 (5), 457-463, 2010
1802010
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
E Dejardin, V Deregowski, M Chapelier, N Jacobs, J Gielen, MP Merville, ...
Oncogene 18 (16), 2567-2577, 1999
1771999
The system can't perform the operation now. Try again later.
Articles 1–20